Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)
Clinical calculations and diagnostic scoring systems like Neonatal Bilirubin Risk & Phototherapy Thresholds (AAP 2022 / Bhutani) frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.
What is the Neonatal Bilirubin Risk & Phototherapy Thresholds (AAP 2022 / Bhutani)?
The Neonatal Bilirubin Risk & Phototherapy Thresholds (AAP 2022 / Bhutani) is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in pediatrics practice. Implements the updated American Academy of Pediatrics (AAP 2022) clinical practice guideline and Bhutani hour-specific nomogram for management of hyperbilirubinemia in newborns ≥ 35 weeks gestation to prevent acute bilirubin encephalopathy and kernicterus. Clinical scoring tools like Neonatal Bilirubin Risk & Phototherapy Thresholds (AAP 2022 / Bhutani) are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).
💡Clinical Pearls & Diagnostic Utility
Prevents bilirubin-induced neurologic dysfunction (BIND), auditory neuropathy, choreoathetoid cerebral palsy, and classic kernicterus.
Formula & Calculation Parameters
The mathematical equation and clinical variables required to calculate Neonatal Bilirubin Risk & Phototherapy Thresholds (AAP 2022 / Bhutani):
Score Interpretation & Clinical Stratification
| Score Range | Clinical Interpretation | Risk Tier |
|---|---|---|
| ≤ 10 | Low Risk Range (mg/dL) | green |
| 10.1 – 18 | Intermediate / Phototherapy Consideration Range (mg/dL) | yellow |
| ≥ 18.1 | Critical / Exchange Transfusion Threshold Range (mg/dL) | red |
When to Exercise Caution
Validated specifically for infants ≥ 35 weeks gestational age; premature infants (< 35 weeks) require lower birth-weight based phototherapy thresholds.
Clinical Review Board
Dr. Muhammad Nouman, MBBS
Capital Medical University | PMDC Reg No: 117744-P
Clinical Audit Status
✓ Verified for 2026 Guidelines
Last updated: 2026-08-08
Peer-Reviewed Medical Literature
- •Kemper AR, et al. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022;150(3):e2022058859.
- •Bhutani VK, et al. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 1999;103(1):6-14.
Related Pediatrics Calculators & Scoring Tools
Explore related clinical calculators, risk stratification indexes, and diagnostic scoring algorithms in Pediatrics:
Wells' Criteria for DVT
Calculates the pre-test probability of Deep Vein Thrombosis.
Glasgow Coma Scale (GCS)
Assesses the level of consciousness after neurological injury.
qSOFA Score
Quick Sequential Organ Failure Assessment for sepsis risk.
Centor Score
Estimates probability of streptococcal pharyngitis.
Mean Arterial Pressure (MAP)
Calculate MAP based on Systolic and Diastolic Blood Pressure.
CURB-65 Score for Pneumonia
Estimates mortality of community-acquired pneumonia to help determine inpatient vs. outpatient treatment.